Osteoporosis is loss of bone density and quality that makes bones break after minor falls. It is silent until the first fracture. A bone health service identifies people at risk, measures bone density, looks for underlying causes and starts treatment to prevent fractures.
Treatment lowers fracture risk by roughly a third to two thirds depending on the drug and the site; it does not make bones unbreakable. It works only with long term adherence, adequate vitamin D and calcium, exercise and falls prevention.
Conditions this service looks after
- Postmenopausal osteoporosis
- Osteoporosis in men
- Steroid induced bone loss
- Fragility fractures of the wrist, hip, spine, shoulder and pelvis
- Vertebral compression fractures with height loss
- Osteopenia with high calculated fracture risk
- Bone loss from early menopause, eating disorders, coeliac disease, thyroid or parathyroid overactivity
- Bone loss from aromatase inhibitors or androgen deprivation therapy
- Vitamin D deficiency and osteomalacia
Tests you may be offered
- DEXA bone density scan: Hip and spine T score; at or below minus 2.5 defines osteoporosis.
- Fracture risk calculation (FRAX): Combines age, risk factors and density into a 10 year probability that guides treatment.
- Spine X-ray or vertebral fracture assessment: Finds silent vertebral fractures, which change treatment.
- Blood tests: Calcium, vitamin D, kidney function, thyroid, parathyroid hormone, blood count, and testosterone in men.
- Tests for secondary causes: Coeliac antibodies and myeloma screen when indicated.
- Bone turnover markers: Sometimes used to monitor response.
Treatments available
- Oral bisphosphonates: Alendronate or risedronate weekly; first line for most people, usually for 5 years before review.
- Intravenous zoledronic acid: A yearly infusion for those who cannot tolerate tablets.
- Denosumab: An injection every 6 months; must not be stopped or delayed without a follow-on drug, because rebound vertebral fractures can occur.
- Bone building agents: Teriparatide or romosozumab for very high risk, followed by a bisphosphonate to keep the gain.
- Vitamin D and calcium: Diet first, supplements to fill the gap.
- Exercise and falls prevention: Weight bearing and resistance training, balance work, vision and medication review, home hazards.
- Vertebroplasty or kyphoplasty: Cement into a painful fresh vertebral fracture for selected patients whose pain is not settling.
When to ask for a specialist opinion
- Any fracture from a standing height fall after age 50
- Height loss of more than 4 cm or a developing stoop
- Steroid tablets for 3 months or longer
- Menopause before age 45
- A parent who had a hip fracture
- Conditions or medicines known to thin bone
Travelling to Türkiye for this care
Osteoporosis is a long term condition managed near home, so it is a poor reason to fly on its own. It fits well into a check-up visit: DEXA scan, blood tests and a specialist consultation can be done in a day or two, with a written treatment plan for your own doctor. Drugs given every 6 or 12 months need a dependable local schedule. A dental check is advised before starting bisphosphonates or denosumab.
Send your reports, scans and a short history and a Clinic-Y coordinator replies within 24 hours with suitable teams and written, all-inclusive proposals side by side. Reviewing your case is free.
الأسئلة المتكررة
What is the difference between osteopenia and osteoporosis?
Osteopenia is mildly reduced density, T score between minus 1 and minus 2.5. It is not a disease in itself; treatment depends on your overall fracture risk.
Are the rare side effects I read about a reason to avoid treatment?
Jaw osteonecrosis and atypical thigh fractures are rare, far rarer than the fractures prevented in people who truly need treatment. Good dental health and treatment reviews keep the risk low.
How often should DEXA be repeated?
Typically every 2 to 3 years on treatment, less often if risk is low.
Does treating bone loss around teeth belong here?
No. Jaw bone loss around teeth is a periodontal or implant dentistry matter and is unrelated to osteoporosis drugs.